ATNF Stock Summary and Trading Ideas (180 Life Sciences Corp. | NASDAQ:ATNF)

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.

180 Life Sciences Corp. trades on the NASDAQ stock market under the symbol ATNF.

As of January 28, 2025, ATNF stock price declined to $1.44 with 123,213 million shares trading.

ATNF has a beta of 0.83, meaning it tends to be less sensitive to market movements. ATNF has a correlation of 0.00 to the broad based SPY ETF.

ATNF has a market cap of $4.57 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ATNF traded as high as $1,356.59 and as low as $1.16.

The top ETF exchange traded funds that ATNF belongs to (by Net Assets): VXF.

ATNF has underperformed the market in the last year with a price return of -67.0% while the SPY ETF gained +24.9%. ATNF has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -66.2% and -3.4%, respectively, while the SPY returned +4.3% and +3.5%, respectively.

ATNF support price is $1.41 and resistance is $1.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ATNF shares will trade within this expected range on the day.